Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q1 2017 · 10-Q
Revenue$57.43M$57.43Mno prior Q1 2016 on file Net Income-$1.17M-$1.17MN/M vs Q1 2016 EPS Diluted-$0.05-$0.05N/M vs Q1 2016 Gross Profit$22,948,000−15.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
Operating Cash Flow-$1,686,000N/M Free Cash Flowderived-$4,693,000N/M Margins · derivedGross margin40.0%
Operating margin-1.0%
Net margin-2.0%
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end